Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications and Adverse Effects of JYNNEOS and ACAM2000 Monkeypox Vaccines
Human monkeypox is an emerging viral zoonotic disease, that has caused highly distinctive, challenging and threatening problems worldwide. The US Food and Drug Administration (FDA) has given interim authorization for the JYNNEOS and ACAM2000 vaccines for the outbreak of monkeypox 2022. The present s...
Main Authors: | Sultan Ayoub Meo, Abeer A. Al-Masri, David C. Klonoff, Abdullah Nasser Alshahrani, Thamir Al-khlaiwi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/11/1971 |
Similar Items
-
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks?
by: Basant E. Katamesh, et al.
Published: (2023-12-01) -
A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox
by: Yuan-Pin Hung, et al.
Published: (2022-10-01) -
Major Advances in Monkeypox Vaccine Research and Development – An Update
by: Deepak Chandran, et al.
Published: (2022-12-01) -
Monkeypox in human pregnancy: an overview
by: Sulaiman Muhammad Daneji, MBBS, FWACS, et al.
Published: (2022-11-01) -
Monkeypox: a global health emergency
by: Ruxandra Ilinca Stilpeanu, et al.
Published: (2023-04-01)